SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense community buzz as investors brace for the late-breaking presentation of 40-week VELA trial data at the upcoming American Academy of Dermatology annual meeting. The stock is seeing significant institutional accumulation and analyst upgrades, with shareholders actively debating the potential for a transformative buyout as the company solidifies its position as a best-in-class leader in the hidradenitis suppurativa treatment landscape.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently facing intense community debate as investors weigh the firm's aggressive dilution strategy against the impact of recent Bitcoin price volatility and external macro pressures. Market participants are actively scrutinizing the company's high-leverage business model, with ongoing discussions polarized between those anticipating a major liquidation risk and others viewing the stock's recent weakness as a prime opportunity for accumulation.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is surging as market participants react to headlines regarding potential diplomatic negotiations to end the ongoing conflict in the Middle East, despite ongoing volatility in oil prices. The community remains deeply divided, with many debating whether the rally is a genuine recovery or a temporary relief pop driven by unverified news and algorithmic positioning.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors gear up for the upcoming release of the company's 2025 Annual Report and earnings call, which are being closely watched for signs of a turnaround. The community is actively debating the stock's potential for a squeeze, citing high short interest and a significant valuation gap compared to its underlying assets, while tracking the company's recent debt reduction efforts.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around its long-standing presence in the market and maintains a high-energy, humorous social media campaign. Investors are actively discussing the token's mass-adoption goals while utilizing the project's decentralized swap options to grow their holdings.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The market is experiencing a high-volatility relief rally driven by conflicting headlines regarding potential war de-escalation in the Middle East and end-of-quarter portfolio rebalancing. While many traders are skeptical and labeling the move a bull trap, the community remains deeply divided, with bears pointing to elevated oil prices as a sign of underlying fragility while bulls are aggressively buying the dip on expectations of institutional support.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is seeing intense retail activity as traders speculate on a potential short squeeze fueled by an exceptionally tight public float and high borrow rates. The community remains deeply divided, with bulls betting on explosive price volatility similar to past market runners, while bears warn of a pump-and-dump scheme driven by lack of institutional support and low trading volumes.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for the treatment of rare kidney diseases, C3G and primary IC-MPGN. Investors are actively discussing the potential impact of this label expansion on long-term revenue growth and its role in bolstering the company's position as a buyout candidate, while monitoring how this news might trigger a short squeeze given the stock's high short interest.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

Mask Network is currently trending as traders closely monitor its price action and technical breakout levels amid active community discussions regarding potential squeezes. Participants are analyzing the asset's float and volume dynamics while sharing various entry and target strategies across social platforms.

Inflection Point Acquisition Corp. IV is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Andrew Stephen Gundlach and Michel Combes on June 24, 2024 and is headquartered in New York, NY.

Merlin Inc.

Merlin Inc. is trending as investors debate the company's long-term growth potential and high-stakes government defense contracts against concerns over share dilution and the inherent risks of a recently public SPAC. The community is actively weighing the firm's autonomous flight technology against aggressive bear cases and technical trading volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMC This is honestly the dumbest 💩 ever!! Can it be more blatantly obvious that this stock is worth more than $1.00......more like 4 digits after 6 years of this BULLSHIT!!

John

Salvatore Falcone

Patrick Sander

juan

Matthew

StockTwits For Android 

AMC Entertainment Holdings

 This is honestly the dumbest 💩 ever!! Can it be more blatantly obvious that this stock is worth more than $1.00......more like 4 digits after 6 years of this BULLSHIT!!

@65Chevelle been holding since the saga began, fully manipulated, but it doesn&#39;t help that AA has been a pure Bozo running this show. New leadership is what will do this stock best, so they can get out of debt, and we can see our baby get back where it needs to be

 been holding since the saga began, fully manipulated, but it doesn't help that AA has been a pure Bozo running this show. New leadership is what will do this stock best, so they can get out of debt, and we can see our baby get back where it needs to be